1 study found for:    17945478 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated Amatuximab for High Mesothelin Cancers
Conditions: Carcinoma, Pancreatic Ductal;   Mesothelioma;   Ovarian Neoplasms;   Carcinoma, Non-Small-Cell Lung
Intervention: Drug: Amatuximab (MORab-009)

Indicates status has not been verified in more than two years